It All Begins with A Spark

The pioneering clinical application of electrohydraulic extracorporeal high-energy shockwaves was in 1980 in lithotripsy – offering a non-invasive method for the treatment of kidney stones. Since the discovery of the great potential of low-energy shockwave therapy for tissue regeneration, many other indications have been added, and the development is continuously on the rise.

At MTS Medical, we are committed advocates of electrohydraulic shockwave technology and have since been among the first providers of this low-energy therapy.

MTS continues to unravel the potential of this original shockwave technology. The innovative and advanced version is known today as MTS Spark Wave – a game changer in modern medicine.

Company History

From2015To

.

Spark Wave® - Revolutionizing Electrohydraulic Shockwave Therapy

Spark Wave Therapy is recognized worldwide for its effective and proven technology. The innovative Spark Wave Technology has revolutionized shockwave therapy with its outstanding quality and has established itself worldwide in dermatology, orthopaedics, urology and veterinary medicine.

The immense regenerative potential is constantly verified thanks to the commitment of our valued MTS Science community of experts, scientists and patients.

Check out the latest evidence from preclinical research and clinical application of our Spark Wave references at mts-science.com.

From2005To

.

USA Partnership and Innovation with SoftWaveTRT

SoftWave Tissue Regeneration Technologies LLC was founded in Woodstock in 2004 by John Warlick and Mark Gronowski with the goal of offering the innovative electrohydraulic Spark Wave Therapy in the USA. The close partnership between SoftWaveTRT and MTS Medical in technological and scientific research, as well as clinical application, has led to the achievement of major milestones and enabled high quality treatments in multiple medical fields.

One of the greatest achievements is the development of the patented SoftWave OP155 applicator – which generates a wide energy field, optimized for deep wound healing and holistic tissue regeneration.

From1996To

.

MTS Medical: The Establishment of a Gold Standard

The great potential of extracorporeal shockwave therapy in regenerative medicine began to show. And so, in 1996, Ralph Reitmajer and Nikolaus Hopfenzitz founded MTS Medical with the idea of innovating the original electrohydraulic shockwave technology. Their claim raised the electrohydraulic shockwave technology to a new dimension and made its therapeutic use effective in a wide range of applications.

From1993To

.

Two Men, One Energy and the Beginning of a Sustainable Partnership

Nikolaus Hopfenzitz, an energetic businessman and lawyer, founded in 1993 the first mobile shockwave clinic in Constance.  His concept was the key to a successful joint venture with the manufacturer Dornier which expanded to 34 outpatient services in German cities within a very short time.

At the same time, a bright young engineer, Ralph Reitmajer, recognized the clinical need for shockwave applicators with improved energy dynamics. Using his experience as a former application specialist at Storz Medical, he founded his company for Mobile Lithotripsy. Motivated by his observations in the new orthopaedic application field, he filed his first patent for the optimized design of electrohydraulic shockwave generation in 1999 (EP09111804).

FromTo1992

.

Extracorporeal Shockwave Therapy Begins to Expand Beyond Borders

Intensive research in the effects of shockwaves on the human body led to the first applications outside of lithotripsy: the treatment of non-healing bone fractures, so-called pseudarthroses, was the starting point for a new field of application in shockwave medicine. Numerous orthopaedic indications followed, as well as other applications in tissue regeneration, such as wound healing and  rehabilitation of urogenital diseases.

FromTo1980

.

Electrohydraulic Shockwave Technology - A Spark that Modernizes Medicine

The exciting phenomenon and physical characteristics of shockwaves were intensively explored in the 1950s for supersonic aircrafts breaking the sound barrier. The first medical application was witnessed in February 1980, when kidney stones were successfully disintegrated at Grosshardern University Hospital in Munich. This extraordinary device was invented by the engineers of the airplane manufacturer Dornier at Lake Constance (Chaussy et al., 1980). In 1983, Dornier’s HM3 lithotripter was the first commercially available lithotripter and marked the beginning of non-invasive extracorporeal shockwave therapy.first commercial lithotripter

Company History

From2015To

.

Spark Wave® -Today’s Leading Electrohydraulic Shockwave Therapy

Today, Spark Wave Therapy is globally recognized in the treatment fields of orthopaedics and traumatology, sexual medicine, wound care and veterinary medicine. Further benefits and potentials of Spark Wave Therapy are constantly being discovered, thanks to the dedication of our inclusive community consisting of Spark Wave users, researchers and patients. Due to this unique cooperation, all findings of Spark Wave are carefully recorded at mts-science.com – our dedicated website that provides insight to all the latest publications based on Spark Wave Technology.

 

From2005To

.

Global Cooperation and Innovation with SoftWaveTRT

SoftWave Tissue Regeneration Technologies LLC was founded in 2004 in Woodstock, Georgia by CEO John Warlick and business partner Mark Gronowski. Spearheading ESWT research and clinical studies in the United States and worldwide, the partnership between SoftWaveTRT and MTS Medical has achieved many breakthroughs, making high quality treatments in broader medical fields possible. One of the greatest achievements is the development of the US-patented unfocused SoftWave OP155 Applicator – the flagship treatment applicator for deep wound healing and tissue regeneration.

 

From1996To

.

MTS Medical: The Continuationof a Legacy

There were no doubts that ESWT would play an important role in the future of modern medicine. In 1996, Nikolaus Hopfenzitz and Ralph Reitmajer founded MTS Medical with the vision to redefine and improve the electrohydraulic shock wave technology. The innovations at MTS Medical brought the quality to a new height, making it possible to expand the use of shock wave therapy from orthopaedics into other medical fields.

 

From1993To

.

Two Person, One Dream and a Beginning of a New Era

Nikolaus Hopfenzitz founded the first ESWT ambulatory clinic in Constance, Germany. The success of this application permitted the expansion of the concept to 34 cities in Germany in the following years for orthopaedic applications. On the other hand, the obvious need for specific applicators with greater energy dynamics was the motivation of a young engineer in the industry, Ralph Reitmajer, who filed his first patent in 1999 on an advanced design for electrohydraulic generators (EP0911804).

 

FromTo1992

.

ESWT Expands Further and Beyond

Intensive research in the effects of shock waves on the human body led to the first applications outside of lithotripsy: the treatment of non-healing bone fractures, so-called pseudarthroses, was the starting point for a new field of application in shock wave medicine. Numerous orthopaedic indications followed, as well as other applications in tissue regeneration. Extracorporeal shock wave therapy (ESWT) opened up an increasing field of application.

 

From1980To1990

.

Electrohydraulic Shockwave Therapy: The Future of Modern Medicine

The phenomenon and physical properties of shock waves were initially investigated in the 1950s. The first true medical application of shockwaves was witnessed in February of 1980, when kidney stones were successfully disintegrated at the Munich University Hospital Grosshadern with extracorporeal shockwave lithotripsy (ESWL) powered by the first electrohydraulic shock wave lithotripter. This extraordinary device was invented by the engineers of the famous airplane manufacturer Dornier at the Lake of Constance (Chaussy et al, 1980). In 1983, the Dornier Lithotripter HM3 (the first commercial lithotripter) became available and marked the start of shock wave application in modern medicine.

 

first commercial lithotripter


Why Choose Us?

Your Multi-Discipline Solution

By choosing Spark Wave Therapy, you can expect a unique and sustainable partnership:

  1. International consultation and support
  2. Sales and marketing solutions
  3. Certified training and quality assessment
  4. Networking opportunities
  5. Research and scientific studies support

MTS Medical’s business solutions ensure all-round care-free services for our clients. We always endeavour to work with you in a value-adding and individualized way.

Experience and Commitment Since 1996

MTS Medical is located in Constance, in the heart of the beautiful region of Lake Constance, a glacial lake located in the foreland of the Alps surrounded by Germany, Austria and Switzerland. The lake is not only the source of the Rhine River, but also the region where Dornier invented the famous airboats and the first shockwave device.

At MTS Medical, we never stop perfecting electrohydraulic shockwave therapy to achieve the best therapeutic quality and patient satisfaction possible.


Join Us - Be a Spark

The career at MTS Medical is highlighted by a diverse and international working environment. In a professional and qualified atmosphere, we collectively develop innovative solutions, we manufacture, consult with our customers, and cooperate with clinics in researching new therapy concepts.

If you would like to be a Spark in our MTS Medical Team, we look forward to receiving your application.


Work with Us. Be the Spark.

With international employees of various expertise and multiple value chains under one roof, our mission at MTS Medical is straight – to provide the best and most sustainable medical solutions through extracorporeal shock wave therapy.

If you share our philosophy and would like to gain exciting experience with an international medical technology manufacturer, we look forward to receiving your application.